![Rank: 8](static/image/common/star_level3.gif) ![Rank: 8](static/image/common/star_level3.gif)
- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Liver Int. 2018 Dec 19. doi: 10.1111/liv.14030. [Epub ahead of print]
Association between serum liver enzymes and all-cause mortality: the Japan Public Health Center-based Prospective Study.
Yuwaki K1,2, Shimazu T1, Yamagiwa Y1, Inoue M1, Goto A1, Yamaji T1, Iwasaki M1, Sawada N1, Tsugane S1; JPHC Study Group.
Author information
1
Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
2
Underwriting and Medical Department, The Dai-ichi Life Insurance Company, Limited, 3-2-3 Toyosu, Koto-ku, Tokyo, 135-8120, Japan.
Abstract
BACKGROUND & AIMS:
The association of serum liver enzyme levels with all-cause mortality in individuals without hepatitis B virus or hepatitis C virus infection is inconsistent. We aimed to investigate all-cause and non-liver disease mortality according to levels of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyltransferase (GGT) stratified by hepatitis virus infection status in a Japanese cohort.
METHODS:
Participants were 7243 men and 13 513 women aged 40-69 years at the baseline survey in 1993-1994. Multivariate-adjusted hazard ratios (HRs) of death from the baseline health checkup to December 2012 were calculated with a Cox proportional hazards model controlling for potential confounding factors.
RESULTS:
During follow-up, 2235 deaths in men and 1901 deaths in women were identified. All serum liver enzymes were associated with all-cause mortality in each sex and hepatitis virus infection status. In participants without infection, those with more than twice the upper level of normal (ULN), which was defined as 30 IU/l for AST and ALT and 50 IU/l for GGT, had a higher risk of non-liver disease mortality compared to those below the ULN (HR 1.69; 95% confidence interval 1.13-2.53, 1.49; 1.02-2.18, 1.39; 1.11-1.73, 1.72; 1.08-2.74, and 1.72; 1.10-2.69 for AST, ALT, and GGT in men and AST and GGT in women, respectively), except for ALT in women.
CONCLUSIONS:
In participants without hepatitis virus infection, serum liver enzyme levels were positively associated with all-cause mortality. Similar associations were also found for non-liver disease mortality. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
KEYWORDS:
Hepatitis viruses; Mortality; Prospective studies; Transferase
PMID:
30566759
DOI:
10.1111/liv.14030 |
|